Gerard Anthony Kennedy

Prof. Gerard Anthony Kennedy

Psychology, School of Health and Life Sciences, Federation University, Australia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
WSWejdan Shahin
Wejdan Shahin
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
Ieva StupansIeva Stupans
Ieva Stupans
Background: Medication adherence is a primary determinant of treatment success in hypertensive patients. One of the challenges for healthcare providers that has received little attention is the impact of patients’ social supports on medication adherence. Objective: This review evaluates the impact of patients’ social supports on medication adherence in hypertensive patients. Methods: A systematic review methodology was used. Pubmed, CINAHL, Embase, and PsycINFO databases were searched systematically for relevant articles. The outcome measure in the studies was medication adherence in hypertension. Results: From 1155 articles, 238 were retained for further assessment, and finally, 14 met the inclusion criteria. Statistically significant positive associations between medication adherence and social support were found in nine studies (p<0.05). Conclusions: This review evaluated the impact of social support on medication adherence and highlighted gaps in the literature regarding the impact of social support on adherence. Family members or peer support may promote better adherence in some patient groups. This review suggests that healthcare providers may need to consider whether patients have appropriate social supports in place which will assist them adhering to and benefiting from treatment recommendations.

11 December 2023 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
FZFei-Yi Zhao
Fei-Yi Zhao
SSSarah Spencer
Sarah Spencer
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
ZZZhen Zheng
Zhen Zheng
RCRussell Conduit
Russell Conduit
YHYuen-Shan Ho
Yuen-Shan Ho

1 October 2021 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
FZFei-Yi Zhao
Fei-Yi Zhao
QFQiangqiang Fu
Qiangqiang Fu
SSSarah Spencer
Sarah Spencer
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
RCRussell Conduit
Russell Conduit
ZZZhen Zheng
Zhen Zheng
Comorbid depression and insomnia are ubiquitous mental complaints among women going through the perimenopausal stage of life and can result in major decline in quality of life. Antidepressive agents combined with/without hypnotics, and/or hormone therapy are currently the most common treatment for perimenopausal depression (PMD) and insomnia (PMI). Balancing the benefits of these pharmacotherapies against the risk of adverse events (AEs) is a difficult task for both clinicians and women. There has been a growing body of research regarding the utilization of acupuncture for treatment of PMD or PMI, whereas no studies of acupuncture for comorbid PMD and PMI have appeared. In this review, we summarize the clinical and preclinical evidence of acupuncture as a treatment for PMD or PMI, and then discuss the potential mechanisms involved and the role of acupuncture in helping women during this transition. Most clinical trials indicate that acupuncture ameliorates not only PMD/PMI but also climacteric symptoms with minimal AEs. It also regulates serum hormone levels. The reliability of trials is however limited due to methodological flaws in most studies. Rodent studies suggest that acupuncture prolongs total sleep time and reduces depression-like behavior in PMI and PMD models, respectively. These effects are possibly mediated through multiple mechanisms of action, including modulating sex hormones, neurotransmitters, hypothalamic-pituitary-adrenal axis/hypothalamic-pituitary-ovary axis, oxidative stress, signaling pathways, and other cellular events. In conclusion, acupuncture is a promising therapeutic strategy for comorbid depression and insomnia during perimenopause. Neuroendocrine modulation is likely to play a major role in mediating those effects. High-quality trials are required to further validate acupuncture’s effectiveness.

26 April 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
FZFei-Yi Zhao
Fei-Yi Zhao
QFQiangqiang Fu
Qiangqiang Fu
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
RCRussell Conduit
Russell Conduit
WWWenzhong Wu
Wenzhong Wu
ZZZhen Zheng
Zhen Zheng
Background. Many women with perimenopausal insomnia (PMI) have sought alternative therapies such as acupuncture because of concerns about risks associated with hormone replacement therapy (HRT) and/or psychotropic drugs. This systematic review aimed to clarify if acupuncture alone or combined with standard Western pharmacotherapy (HRT and/or psychotropic drugs) is more effective in ameliorating PMI in comparison to pharmacotherapy alone. Methods. Randomized controlled trials (RCTs) of PMI treatment via acupuncture alone or combined with Western pharmacotherapy versus Western pharmacotherapy were searched for from eleven databases from inception to March 2020. Cochrane criteria were followed. Results. Fifteen studies involving 1410 women were analyzed. Meta-analysis indicated that acupuncture significantly reduced the global scores of Pittsburgh Sleep Quality Index (PSQI) [MD = −2.38, 95% CI (−3.38, −1.37), < 0.01] and Kupperman Index [MD = −5.95, 95% CI (−10.68, −1.21), = 0.01], compared with hypnotics. Acupuncture combined with hypnotics was more effective than hypnotics alone in decreasing PSQI scores [MD = −3.13, 95% CI (−5.43, −0.83), < 0.01]. Too few RCTs were available to investigate the clinical efficacy differences between acupuncture and HRT/psychotropic drugs other than hypnotics. Conclusions. Despite limited evidence, in comparison to hypnotics, acupuncture was associated with significant improvements in PMI, and reductions of other menopausal symptoms. This finding suggests that acupuncture may be a useful addition to treatment for PMI.

11 December 2018 in Ethnicity & Health
Verified
Journal Article
Closed access
WSWejdan Shahin
Wejdan Shahin
ISIeva Stupans
Ieva Stupans
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
Objective: To evaluate beliefs, and attitudes about health of refugees with chronic conditions such as diabetes mellitus type 2, hypertension, chronic obstructive pulmonary disease, and posttraumatic stress disorder and the consequent effects on self-care in comparison to resident populations. Design: A systematic review methodology was used. PubMed, Embase, PsycINFO and CINAHL databases were searched for relevant articles. The main terms analysed were health beliefs, chronic conditions and refugee populations. From 844 articles, 45 were retained for further assessment, and finally 5 met the inclusion criteria. Results: Differences in the health beliefs, attitudes and self-care management approaches of refugees compared to resident populations were identified in two studies. The remaining three papers did not make comparisons between the refugees and the resident population, nor did they specifically explore the refugees’ health beliefs. Of the five studies, three were carried out in Sweden and two in the US. Refugees who have poorer mental and physical health as well as higher prevalence of chronic diseases than the populations among which they resettle seem to lack the knowledge about their illness, symptoms and self-management and thus are less able to control their chronic conditions. Conclusion: The findings highlighted the deficiency in the literature of studies which examine health beliefs and attitudes of minority groups such as refugees who have chronic conditions. The findings also gave insight to the need for a distinctive understanding of refugee health and the management of chronic conditions in comparison to other non-refugee migrant groups. Further research is needed to fully understand the differences between refugees and local populations in terms health beliefs, chronic disease and self-management.

28 September 2019 in Disability and Rehabilitation
Verified
Journal Article
Closed access
HOHumberto Oraison
Humberto Oraison
GKGerard Anthony Kennedy
Gerard Anthony Kennedy
Background: Chronic back pain is characterized by its duration and poor response to medical interventions and is a major health problem. Treatment up-take, adherence, and social support are key issues and are vital for recovery and functionality. However, there is limited research on the role of social support and treatment uptake and adherence for chronic back pain. Aim: The aim of this study was to explore the impact of social support in terms of treatment uptake and adherence in chronic back pain patients in Australia. Methods: Two hundred and one adult men and women completed a battery of questionnaires that assessed levels of social support and disability and treatment uptake and adherence. Results: Stepwise multiple regression predicting treatment participation, produced a significant model that included participant’s age and level of social support and accounted for 14% of the variance, F(2,179) = 14.10, p < 0.001, adj R2 = 0.14. Life control, affective distress and level of social support scores accounted for 26% of the variance in disability levels F(3,179) = 21.42, p < 0.001, adj R2 = 0.26. Conclusion: The findings indicated that age, social support had a significant positive effect on the number of treatment sessions attended by participants and that life control, affective distress, and level of social support were negatively related to disability levels. The findings support interdisciplinary approaches, including social interventions as important part of any chronic back pain treatment.